Correlation Between Inhibrx and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Inhibrx and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Pasithea Therapeutics.
Diversification Opportunities for Inhibrx and Pasithea Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Pasithea is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Pasithea Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 10.08 times less risky than Pasithea Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 1.13 in Pasithea Therapeutics Corp on September 2, 2024 and sell it today you would earn a total of 0.90 from holding Pasithea Therapeutics Corp or generate 79.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 50.0% |
| Values | Daily Returns |
Inhibrx vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Inhibrx |
| Pasithea Therapeutics |
Inhibrx and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Pasithea Therapeutics
The main advantage of trading using opposite Inhibrx and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Pasithea Therapeutics vs. Tff Pharmaceuticals | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx | Pasithea Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |